Specific mutations: There is a significantly higher incidence of G12V mutation in the H-Ras protein among bladder carcinoma samples (G12V = 60% of the total number of affected H-Ras samples identified), while G12D and Q61R were at 8% and 7% respectively. Here, HRAS is linked to urinary bladder carcinoma.